These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19692702)

  • 1. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
    Pallasch CP; Patz M; Park YJ; Hagist S; Eggle D; Claus R; Debey-Pascher S; Schulz A; Frenzel LP; Claasen J; Kutsch N; Krause G; Mayr C; Rosenwald A; Plass C; Schultze JL; Hallek M; Wendtner CM
    Blood; 2009 Oct; 114(15):3255-64. PubMed ID: 19692702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
    Patz M; Pallasch CP; Wendtner CM
    Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation.
    Zou ZJ; Fan L; Wang L; Xu J; Zhang R; Tian T; Li JY; Xu W
    Oncotarget; 2015 Jan; 6(2):1276-85. PubMed ID: 25361012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
    Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
    Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.
    Sampath D; Calin GA; Puduvalli VK; Gopisetty G; Taccioli C; Liu CG; Ewald B; Liu C; Keating MJ; Plunkett W
    Blood; 2009 Apr; 113(16):3744-53. PubMed ID: 19096009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of miR-15/16 in CLL.
    Pekarsky Y; Croce CM
    Cell Death Differ; 2015 Jan; 22(1):6-11. PubMed ID: 24971479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis.
    Marton S; Garcia MR; Robello C; Persson H; Trajtenberg F; Pritsch O; Rovira C; Naya H; Dighiero G; Cayota A
    Leukemia; 2008 Feb; 22(2):330-8. PubMed ID: 17989717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
    Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
    PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies.
    Al-Harbi S; Choudhary GS; Ebron JS; Hill BT; Vivekanathan N; Ting AH; Radivoyevitch T; Smith MR; Shukla GC; Almasan A
    Mol Cancer; 2015 Nov; 14():185. PubMed ID: 26537004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells.
    Willimott S; Wagner SD
    J Biol Chem; 2012 Jan; 287(4):2608-17. PubMed ID: 22139839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.
    Rodríguez-Vicente AE; Quwaider D; Benito R; Misiewicz-Krzeminska I; Hernández-Sánchez M; de Coca AG; Fisac R; Alonso JM; Zato C; de Paz JF; García JL; Sarasquete ME; Hernández JÁ; Corchado JM; González M; Gutiérrez NC; Hernández-Rivas JM
    BMC Cancer; 2015 Apr; 15():238. PubMed ID: 25880332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.